Format

Send to

Choose Destination
Pediatr Nephrol. 2011 Jun;26(6):933-7. doi: 10.1007/s00467-011-1803-3. Epub 2011 Feb 22.

Results of medical treatment and metabolic risk factors in children with urolithiasis.

Author information

1
Department of Pediatrics, Division of Pediatric Nephrology, Fırat University Faculty of Medicine, TR-23119, Elazığ, Turkey. mkgurgoze@yahoo.com

Abstract

Data on conservative treatment in children with urolithiasis are limited. The aim of the study was to determine the metabolic etiology and results of conservative treatment in children with urolithiasis. We evaluated the clinical presentation and metabolic features of 112 children with urolithiasis. The mean age at diagnosis of urolithiasis was 3.9 (range 0.1-18) years, and follow-up duration was 16.7 (range 1-36) months. The most common presenting symptoms were flank or abdominal pain and restlessness (25%). Urine analysis revealed metabolic abnormalities in 92% of cases, including hypocitraturia (42%), hyperoxaluria (32.1%), hypercalcuria (25%), hyperuricosuria (9.8%), and cystinuria (2.7%). Patients who had metabolic risk factors were treated according to underlying metabolic abnormalities. About half of these patients were stone free or stones were diminished in size. These results showed that early recognition and treatment of urinary metabolic abnormalities will reduce the number of invasive procedures and renal damage in children with urolithiasis.

PMID:
21340610
DOI:
10.1007/s00467-011-1803-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center